DNMT3A mutations in exon 23 are associated with improved survival in AML patients treated with Azacytidine plus standard chemotherapyPetra Tschanter, Carsten Müller‐Tidow, Stefanie Goellner et al.|Kölner Universitäts PublikationsServer (Universität zu Köln)|2015Cited by 0
Small Scale Surface Roughness of RyuguK. A. Otto, F. Trauthan, Rutu Parekh et al.|elib (German Aerospace Center)|2019Cited by 0